John W. Hanna is the President and Chief Executive Officer at CAREDX INC, a leading precision medicine solutions company focused on the discovery, development, and commercialization of diagnostic solutions for transplant patients. With a robust background in the life sciences and healthcare industries, Hanna has been instrumental in steering CAREDX towards significant growth and innovation. Prior to joining CAREDX, he held various leadership positions at companies such as Luminex Corporation, where he served as President and CEO, and at Affymetrix, where he was Senior Vice President and General Manager of the Genetic Analysis business. Under Hanna's leadership, CAREDX has expanded its portfolio of diagnostic solutions, enhancing the company's ability to improve patient outcomes in the transplant community. His strategic vision has led to the development of cutting-edge technologies and the strengthening of CAREDX's market position. Hanna's commitment to advancing healthcare through precision medicine is evident in the company's ongoing research and development efforts, as well as its collaborations with leading medical institutions. His leadership style emphasizes innovation, patient-centricity, and operational excellence, which have been key drivers of CAREDX's success. In addition to his role at CAREDX, John W. Hanna is actively involved in the broader healthcare and life sciences community. He serves on the board of directors for several organizations and is a frequent speaker at industry conferences, where he shares insights on the future of precision medicine and transplant diagnostics. Hanna's dedication to improving patient care and his ability to navigate the complex landscape of healthcare innovation make him a respected leader in the field.